Product Images Sivextro

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Sivextro NDC 72000-310 by Nabriva Therapeutics Us, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

sivextro nabriva 01

sivextro nabriva 01

sivextro nabriva 02

sivextro nabriva 02

This is a description of a medication in tablet form with a usual dosage of 200mg orally once daily. The tablet contains tetizolidphosphate and is manufactured for Nabriva Therapeutics US, Inc. The packaging includes an NDC code and information on the encoding area reserved for serialization barcode, GTIN, serial number, expiry, and lot. The medication is USP controlled at room temperature and was formulated in Canada.*

sivextro nabriva 03

sivextro nabriva 03

This is a label of medicine, "Sivextro" which contains tedizolid phosphate. It comes in 6 tablets with each having 200 mg per tablet. It needs a prescription. The text also includes some medical codes and instructions for use.*

sivextro nabriva 04

sivextro nabriva 04

This is a description of Sivextro® SRR DI e 200mg injection for intravenous infusion. The vial contains inactive ingredients such as mannitol, sodium, and other substances. There is a reserved space for encoding the 2D Serialization Barcode, GTIN, Serial Number, Expiry, and Lot. The product is to be stored in a Rxonly sterile environment at temperatures between 20-25°C or 15°C to 46°C. It is not compatible with nd complce normtion oG Sionscoea Snd ampisrtion.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.